Molecular biology research in neuropsychiatry: India's contribution
- PMID: 21836667
- PMCID: PMC3146196
- DOI: 10.4103/0019-5545.69223
Molecular biology research in neuropsychiatry: India's contribution
Abstract
Neuropsychiatric disorders represent the second largest cause of morbidity worldwide. These disorders have complex etiology and patho-physiology. The major lacunae in the biology of the psychiatric disorders include genomics, biomarkers and drug discovery, for the early detection of the disease, and have great application in the clinical management of disease. Indian psychiatrists and scientists played a significant role in filling the gaps. The present annotation provides in depth information related to research contributions on the molecular biology research in neuropsychiatric disorders in India. There is a great need for further research in this direction as to understand the genetic association of the neuropsychiatric disorders; molecular biology has a tremendous role to play. The alterations in gene expression are implicated in the pathogenesis of several neuropsychiatric disorders, including drug addiction and depression. The development of transgenic neuropsychiatric animal models is of great thrust areas. No studies from India in this direction. Biomarkers in neuropsychiatric disorders are of great help to the clinicians for the early diagnosis of the disorders. The studies related to gene-environment interactions, DNA instability, oxidative stress are less studied in neuropsychiatric disorders and making efforts in this direction will lead to pioneers in these areas of research in India. In conclusion, we provided an insight for future research direction in molecular understanding of neuropsychiatry disorders.
Keywords: D1 receptors; DNA conformation; DNA stability; Depression; autism; bipolar disorders; cell death; dementia; diet; enzymes; genes; mutations; pedigree; sexual dysfunction; trace metals.
Conflict of interest statement
Similar articles
-
Bioinformatics approach to understanding interacting pathways in neuropsychiatric disorders.Methods Mol Biol. 2014;1168:157-72. doi: 10.1007/978-1-4939-0847-9_9. Methods Mol Biol. 2014. PMID: 24870135 Review.
-
The neuropsychiatry of Parkinson's disease and related disorders.Psychiatr Clin North Am. 2004 Dec;27(4):801-25. doi: 10.1016/j.psc.2004.07.001. Psychiatr Clin North Am. 2004. PMID: 15550293 Review.
-
Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders.Genes Brain Behav. 2003 Dec;2(6):350-64. doi: 10.1046/j.1601-1848.2003.00049.x. Genes Brain Behav. 2003. PMID: 14653307 Review.
-
Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database.Mol Psychiatry. 2016 Feb;21(2):290-7. doi: 10.1038/mp.2015.40. Epub 2015 Apr 7. Mol Psychiatry. 2016. PMID: 25849321 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
Cited by
-
Serotonin transporter gene polymorphism and psychiatric disorders: is there a link?Indian J Psychiatry. 2011 Oct;53(4):289-99. doi: 10.4103/0019-5545.91901. Indian J Psychiatry. 2011. PMID: 22303036 Free PMC article.